3 hours ago
1
Images we create and what actually happens are always beautiful when we have imagination./iStock via Getty Images
- AbbVie (NYSE:ABBV) said that a phase 3b/4 head-to-head trial pitting Rinvoq (upadacitinib) against Humira (adalimumab) in rheumatoid arthritis demonstrated the former's superiority over the latter.
- Results from the SELECT-SWITCH trial found that a significantly higher proportion of patients who received
English (US) ·